Possibia

358

Last Update Posted: 2017-01-12

Recruiting has ended

All Genders

accepted

21 Years-59 Years

0 Estimated Participants

No Expanded Access

Interventional Study

Does not accept healthy volunteers

Evaluation of Lofexidine for Treatment of Opioid Withdrawal - 7

The purpose of this study is to determine the safety of lofexidine in the treatment of opiate withdrawal. Preliminary data will also be obtained to assess the ability of lofexidine to alleviate opiate withdrawal signs and symptoms.

Eligibility

Relevant conditions:

Opioid-Related Disorders

Substance-Related Disorders

If you aren't sure if you meet the criteria above speak to your healthcare professional. Criteria may be updated but not reflected here, do not hesitate to contact the study if you think are close to fitting criteria.

locations

Contact Information

Overall Contact

No valid contacts available

Data sourced from ClinicalTrials.gov